Clinicians’ views of prescribing oral and intravenous bisphosphonates for osteoporosis: a qualitative study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Clinicians’ views of prescribing oral and intravenous bisphosphonates for osteoporosis: a qualitative study ; volume:24 ; number:1 ; day:29 ; month:9 ; year:2023 ; pages:1-10 ; date:12.2023
BMC musculoskeletal disorders ; 24, Heft 1 (29.9.2023), 1-10, 12.2023
- Urheber
-
Bishop, Simon
Narayanasamy, Melanie Jay
Paskins, Zoe
Corp, Nadia
Bastounis, Anastasios
Griffin, Jill
Gittoes, Neil
Leonardi-Bee, Jo
Langley, Tessa
Sahota, Opinder
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12891-023-06865-1
- URN
-
urn:nbn:de:101:1-2024020613380545549811
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bishop, Simon
- Narayanasamy, Melanie Jay
- Paskins, Zoe
- Corp, Nadia
- Bastounis, Anastasios
- Griffin, Jill
- Gittoes, Neil
- Leonardi-Bee, Jo
- Langley, Tessa
- Sahota, Opinder
- SpringerLink (Online service)
Ähnliche Objekte (12)
A reappraisal of generic bisphosphonates in osteoporosis
Novel formulations of oral bisphosphonates in the treatment of osteoporosis
Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Sickle cell bone disease and response to intravenous bisphosphonates in children
Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
The clinician’s guide to prevention and treatment of osteoporosis
Bisphosphonates and Implants
A reappraisal of generic bisphosphonates in osteoporosis
Novel formulations of oral bisphosphonates in the treatment of osteoporosis
Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Sickle cell bone disease and response to intravenous bisphosphonates in children
Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
The clinician’s guide to prevention and treatment of osteoporosis
Bisphosphonates and Implants
A reappraisal of generic bisphosphonates in osteoporosis
Novel formulations of oral bisphosphonates in the treatment of osteoporosis
Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Sickle cell bone disease and response to intravenous bisphosphonates in children
Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
The clinician’s guide to prevention and treatment of osteoporosis